Anagen Therapeutics is an emerging biotechnology company focused on therapies for androgen and nuclear receptor-related diseases. Specific targets for its products under development include: Prostate Disease © Nucleus Communications Cardiovascular Disease © Medical Imagery Neurodegenerative Disease © Medical Imagery Skin Disease © Nucleus Communications